Catalonia Suicide Risk Code Epidemiology (CSRC-Epi) study: protocol for a population-representative nested case-control study of suicide attempts in Catalonia, Spain.

epidemiology mental health psychiatry public health statistics & research methods suicide & self-harm

Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
12 07 2020
Historique:
entrez: 15 7 2020
pubmed: 15 7 2020
medline: 16 3 2021
Statut: epublish

Résumé

Suicide attempts represent an important public health burden. Centralised electronic health record (EHR) systems have high potential to provide suicide attempt surveillance, to inform public health action aimed at reducing risk for suicide attempt in the population, and to provide data-driven clinical decision support for suicide risk assessment across healthcare settings. To exploit this potential, we designed the Catalonia Suicide Risk Code Epidemiology (CSRC-Epi) study. Using centralised EHR data from the entire public healthcare system of Catalonia, Spain, the CSRC-Epi study aims to estimate reliable suicide attempt incidence rates, identify suicide attempt risk factors and develop validated suicide attempt risk prediction tools. The CSRC-Epi study is registry-based study, specifically, a two-stage exposure-enriched nested case-control study of suicide attempts during the period 2014-2019 in Catalonia, Spain. The primary study outcome consists of first and repeat attempts during the observation period. Cases will come from a case register linked to a suicide attempt surveillance programme, which offers in-depth psychiatric evaluations to all Catalan residents who present to clinical care with any suspected risk for suicide. Predictor variables will come from centralised EHR systems representing all relevant healthcare settings. The study's sampling frame will be constructed using population-representative administrative lists of Catalan residents. Inverse probability weights will restore representativeness of the original population. Analysis will include the calculation of age-standardised and sex-standardised suicide attempt incidence rates. Logistic regression will identify suicide attempt risk factors on the individual level (ie, relative risk) and the population level (ie, population attributable risk proportions). Machine learning techniques will be used to develop suicide attempt risk prediction tools. This protocol is approved by the Parc de Salut Mar Clinical Research Ethics Committee (2017/7431/I). Dissemination will include peer-reviewed scientific publications, scientific reports for hospital and government authorities, and updated clinical guidelines. NCT04235127.

Identifiants

pubmed: 32660952
pii: bmjopen-2020-037365
doi: 10.1136/bmjopen-2020-037365
pmc: PMC7359191
doi:

Banques de données

ClinicalTrials.gov
['NCT04235127']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e037365

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: DP has received grants and also served as consultant or advisor for Angelini, Janssen, Lundbeck and Servier. The other authors have no competing interests to declare.

Références

Eur Psychiatry. 2005 Mar;20(2):115-20
pubmed: 15797695
J Biomed Inform. 2007 Aug;40(4):398-409
pubmed: 17632039
Int J Environ Res Public Health. 2018 Jul 06;15(7):
pubmed: 29986446
Health Rep. 2011 Sep;22(3):15-22
pubmed: 22106785
J Affect Disord. 2015 Nov 1;186:254-60
pubmed: 26254617
Arch Suicide Res. 2012;16(4):287-302
pubmed: 23137219
J Abnorm Child Psychol. 2017 Jul;45(5):971-983
pubmed: 27761783
Scand J Public Health. 2019 Feb;47(1):9-17
pubmed: 29207932
Wiley Interdiscip Rev Syst Biol Med. 2017 May;9(3):
pubmed: 28207198
Br J Psychiatry. 2008 Feb;192(2):98-105
pubmed: 18245022
World Psychiatry. 2016 Jun;15(2):135-45
pubmed: 27265704
J Clin Epidemiol. 2018 Jan;93:84-87
pubmed: 28951107
Eur J Epidemiol. 2015 Mar;30(3):197-207
pubmed: 25446306
Aust N Z J Psychiatry. 2017 Feb;51(2):151-160
pubmed: 26921278
Epidemiol Psychiatr Sci. 2019 Oct 01;29:e62
pubmed: 31571561
Mol Psychiatry. 2020 Jan;25(1):168-179
pubmed: 31570777
Natl Health Stat Report. 2018 Feb;(108):1-19
pubmed: 29616901
Commun Stat Appl Methods. 2013 Nov;20(6):455-466
pubmed: 28503512
Stat Appl Genet Mol Biol. 2007;6:Article25
pubmed: 17910531
Psychiatr Serv. 2015 Feb 1;66(2):121-6
pubmed: 25270296
BMJ. 2019 Feb 6;364:l94
pubmed: 31339847
J Gen Intern Med. 2014 Jun;29(6):870-7
pubmed: 24567199
Comput Math Methods Med. 2017;2017:7847531
pubmed: 29312464
Int J Epidemiol. 2019 Oct 1;48(5):1636-1649
pubmed: 30907424
Genet Epidemiol. 2016 Nov;40(7):570-578
pubmed: 27313007
Psychol Med. 2016 Jan;46(2):225-36
pubmed: 26370729
Suicide Life Threat Behav. 2014 Oct;44(5):497-509
pubmed: 24494741
JMIR Res Protoc. 2018 Dec 07;7(12):e11135
pubmed: 30530459
Am J Public Health. 2004 Jan;94(1):37-45
pubmed: 14713694
BMC Psychiatry. 2019 May 23;19(1):158
pubmed: 31122215
Stat Med. 2014 Oct 30;33(24):4215-26
pubmed: 24919979
Mol Psychiatry. 2017 Apr;22(4):544-551
pubmed: 27431294
JAMA Psychiatry. 2014 Feb;71(2):119-27
pubmed: 24306041
Int J Environ Res Public Health. 2019 Nov 19;16(22):
pubmed: 31752375
J Public Health Manag Pract. 2002 May;8(3):11-7
pubmed: 15156620
JAMA Psychiatry. 2019 Jun 1;76(6):642-651
pubmed: 30865249
Community Ment Health J. 2016 Jul;52(5):534-40
pubmed: 26831304
Suicide Life Threat Behav. 2009 Oct;39(5):548-57
pubmed: 19929154
Annu Rev Public Health. 2016;37:61-81
pubmed: 26667605

Auteurs

Philippe Mortier (P)

Health Services Research Group, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain pmortier@imim.es.
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Gemma Vilagut (G)

Health Services Research Group, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Beatriz Puértolas Gracia (B)

Health Services Research Group, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Ana De Inés Trujillo (A)

Health Services Research Group, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
Department of Social Psychology, Autonomous University of Barcelona (UAB), Cerdanyola del Vallès, Barcelona, Spain.

Itxaso Alayo Bueno (I)

Health Services Research Group, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Laura Ballester Coma (L)

Health Services Research Group, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Department of Psychology, University of Girona (UdG), Girona, Spain.

María Jesús Blasco Cubedo (MJ)

Health Services Research Group, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Department of Health & Experimental Sciences, Pompeu Fabra University (UPF), Barcelona, Spain.

Narcís Cardoner (N)

Depression and Anxiety Program, Department of Mental Health, Parc Taulí Sabadell, Hospital Universitari, Sabadell, Spain.
Department of Psychiatry and Legal Medicine, Universitat Autònoma de Barcelona (UAB), Cerdanyola Del Vallès, Barcelona, Spain.
Centro de Investigación en Red de Salud Mental, CIBERSAM, Madrid, Spain.
Institut d'Investigació i Innovació Parc Taulí (I3PT), Sabadell, Barcelona, Spain.

Cristina Colls (C)

Agència de Qualitat i Avaluació Sanitàries de Catalunya - Health Evaluation and Quality Agency of Catalonia (AQuAS), Catalan Health Department, Barcelona, Spain.

Matilde Elices (M)

Centro de Investigación en Red de Salud Mental, CIBERSAM, Madrid, Spain.
Neurosciences Research Programme, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.

Anna Garcia-Altes (A)

CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Agència de Qualitat i Avaluació Sanitàries de Catalunya - Health Evaluation and Quality Agency of Catalonia (AQuAS), Catalan Health Department, Barcelona, Spain.
Institut d'Investigació Biomèdica (IIB Sant Pau), Barcelona, Spain.

Manel Gené Badia (M)

Legal Medicine Unit, Faculty of Medicine, University of Barcelona, Barcelona, Spain.

Javier Gómez Sánchez (J)

Health Services Research Group, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.

Mario Martín Sánchez (M)

Preventive Medicine and Public Health Training Unit PSMar-UPF-ASPB, Parc de Salut Mar, Agència de Salut Pública de Barcelona, Pompeu Fabra University, Barcelona, Spain.

Rosa Morros (R)

Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.
Departament de Farmacologia, de Terapèutica i de Toxicologia, Universitat Autònoma de Barcelona, Barcelona, Spain.
Institut Català de la Salut (ICS), Metropolitana Nord, Barcelona, Spain.

Bibiana Prat Pubill (B)

Master Plan on Mental Health and Addictions, Ministry of Health, Catalan Government, Barcelona, Spain.

Ping Qin (P)

National Centre for Suicide Research and Prevention, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Lars Mehlum (L)

National Centre for Suicide Research and Prevention, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Ronald C Kessler (RC)

Department of Health Care Policy, Harvard Medical School, Boston, MA, USA.

Diego Palao (D)

Depression and Anxiety Program, Department of Mental Health, Parc Taulí Sabadell, Hospital Universitari, Sabadell, Spain.
Department of Psychiatry and Legal Medicine, Universitat Autònoma de Barcelona (UAB), Cerdanyola Del Vallès, Barcelona, Spain.
Centro de Investigación en Red de Salud Mental, CIBERSAM, Madrid, Spain.
Institut d'Investigació i Innovació Parc Taulí (I3PT), Sabadell, Barcelona, Spain.

Víctor Pérez Sola (V)

Department of Psychiatry and Legal Medicine, Universitat Autònoma de Barcelona (UAB), Cerdanyola Del Vallès, Barcelona, Spain.
Centro de Investigación en Red de Salud Mental, CIBERSAM, Madrid, Spain.
Neurosciences Research Programme, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
Institut de Neuropsiquiatria i Addiccions, Hospital del Mar, Barcelona, Spain.

Jordi Alonso (J)

Health Services Research Group, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Department of Health & Experimental Sciences, Pompeu Fabra University (UPF), Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH